Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-062792
Filing Date
2008-03-21
Accepted
2008-03-21 15:48:23
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 634023
2 FIRST AMENDMENT TO EMPLOYMENT LETTER AGREEMENT dex105a.htm EX-10.5(A) 6566
3 CONSENT OF KPMG LLP dex231.htm EX-23.1 2352
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9105
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9104
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 2881
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 2885
  Complete submission text file 0001193125-08-062792.txt   668537
Mailing Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021
Business Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

EIN.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-20897 | Film No.: 08705196
SIC: 2834 Pharmaceutical Preparations